Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

Medicine, Immunology, Pharmacology +11

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Richard Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism · 2011 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Bevra H. Hahn, Maureen McMahon, Alan Wilkinson et al. · Arthritis Care & Research · 2012 · 1.5K citations

Medicine, Immunology, Nephrology +15

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Brad H. Rovin, Richard Furie, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 1.4K citations

Medicine, Immunology, Pharmacotherapy +16

Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis

Ellen M. Ginzler, Mary Anne Dooley, Cynthia Aranow et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Medicine, Nephrology, Pharmacotherapy +14